<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table4" position="float"><label>Table 4.</label><caption><title>Top 20 significantly enriched pathways as determined by Gene Ontology (GO) enrichment analysis in dithranol-treated lesional skin after 6 days compared to baseline from 15 patients with psoriasis.</title><p>(GO was done using Cytoscape software [<xref ref-type="bibr" rid="bib6">Bindea et al., 2009</xref>; <xref ref-type="bibr" rid="bib72">Shannon et al., 2003</xref>]; a.o.&#160;=&#160;among others).</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">GOID</th><th valign="top">GO term</th><th valign="top">P-Value</th><th valign="top">% Associated Genes</th><th valign="top">Associated genes found</th></tr></thead><tbody><tr><td valign="top">GO:0001533</td><td valign="top">Cornified envelope</td><td valign="top">3.8E-12</td><td valign="top">10.45</td><td valign="top">FLG, HRNR, KRT2, LCE1A, LCE1C, LCE2D, SPRR2F</td></tr><tr><td valign="top">GO:0031424</td><td valign="top">Keratinization</td><td valign="top">7.7E-12</td><td valign="top">3.93</td><td valign="top">CASP14, FLG, HRNR, KRT2, KRT73, LCE1A, LCE1C, LCE2D, SPRR2F</td></tr><tr><td valign="top">GO:0030216</td><td valign="top">Keratinocyte differentiation</td><td valign="top">79.0E-12</td><td valign="top">3.02</td><td valign="top">CASP14, FLG, HRNR, KRT2, KRT73, LCE1A, LCE1C, LCE2D, SPRR2F</td></tr><tr><td valign="top">GO:0018149</td><td valign="top">Peptide cross-linking</td><td valign="top">300.0E-12</td><td valign="top">9.84</td><td valign="top">FLG, KRT2, LCE1A, LCE1C, LCE2D, SPRR2F</td></tr><tr><td valign="top">GO:0070268</td><td valign="top">Cornification</td><td valign="top">12.0E-9</td><td valign="top">5.31</td><td valign="top">CASP14, FLG, KRT2, KRT73, LCE1A, SPRR2F</td></tr><tr><td valign="top">GO:0004168</td><td valign="top">Receptor CXCR2 binds ligands CXCL1 to 7</td><td valign="top">1.0E-6</td><td valign="top">33.33</td><td valign="top">CXCL5, CXCL8, PPBP</td></tr><tr><td valign="top">GO:0042379</td><td valign="top">Chemokine receptor binding</td><td valign="top">5.4E-6</td><td valign="top">6.25</td><td valign="top">CXCL5, CXCL8, DEFB4A, PPBP</td></tr><tr><td valign="top">GO:0045236</td><td valign="top">CXCR chemokine receptor binding</td><td valign="top">6.0E-6</td><td valign="top">18.75</td><td valign="top">CXCL5, CXCL8, PPBP</td></tr><tr><td valign="top">GO:0061436</td><td valign="top">Establishment of skin barrier</td><td valign="top">18.0E-6</td><td valign="top">13.04</td><td valign="top">FLG, FLG2, HRNR</td></tr><tr><td valign="top">GO:0033561</td><td valign="top">Regulation of water loss via skin</td><td valign="top">21.0E-6</td><td valign="top">12.00</td><td valign="top">FLG, FLG2, HRNR</td></tr><tr><td valign="top">GO:0004657</td><td valign="top">IL-17 signaling pathway</td><td valign="top">21.0E-6</td><td valign="top">4.30</td><td valign="top">CXCL5, CXCL8, DEFB4A, DEFB4B</td></tr><tr><td valign="top">GO:0007874</td><td valign="top">Keratin filament formation</td><td valign="top">21.0E-6</td><td valign="top">4.17</td><td valign="top">FLG, KRT2, KRT73, SPRR2F</td></tr><tr><td valign="top">GO:0030593</td><td valign="top">Neutrophil chemotaxis</td><td valign="top">21.0E-6</td><td valign="top">4.17</td><td valign="top">CXCL5, CXCL8, PPBP, TREM1</td></tr><tr><td valign="top">GO:1990266</td><td valign="top">Neutrophil migration</td><td valign="top">27.0E-6</td><td valign="top">3.85</td><td valign="top">CXCL5, CXCL8, PPBP, TREM1</td></tr><tr><td valign="top">GO:0071621</td><td valign="top">Granulocyte chemotaxis</td><td valign="top">38.0E-6</td><td valign="top">3.31</td><td valign="top">CXCL5, CXCL8, PPBP, TREM1</td></tr><tr><td valign="top">GO:1902622</td><td valign="top">Regulation of neutrophil migration</td><td valign="top">45.0E-6</td><td valign="top">7.50</td><td valign="top">CXCL5, CXCL8, PPBP</td></tr><tr><td valign="top">GO:0071622</td><td valign="top">Regulation of granulocyte chemotaxis</td><td valign="top">71.0E-6</td><td valign="top">5.66</td><td valign="top">CXCL5, CXCL8, PPBP</td></tr><tr><td valign="top">GO:0030104</td><td valign="top">Water homeostasis</td><td valign="top">130.0E-6</td><td valign="top">4.00</td><td valign="top">FLG, FLG2, HRNR</td></tr><tr><td valign="top">GO:0002690</td><td valign="top">Positive regulation of leukocyte chemotaxis</td><td valign="top">120.0E-6</td><td valign="top">3.30</td><td valign="top">CXCL5, CXCL8, PPBP</td></tr><tr><td valign="top">GO:0004867</td><td valign="top">Serine-type endopeptidase inhibitor activity</td><td valign="top">79.0E-6</td><td valign="top">3.00</td><td valign="top">SERPINB1, SERPINB12, SPINK7</td></tr></tbody></table></table-wrap>